<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rhee</surname>
    <given-names>SY</given-names>
   </name>
   <name>
    <surname>Varghese</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Holmes</surname>
    <given-names>SP</given-names>
   </name>
   <name>
    <surname>Van Zyl</surname>
    <given-names>GU</given-names>
   </name>
   <name>
    <surname>Steegen</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Boyd</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Cooper</surname>
    <given-names>DA</given-names>
   </name>
   <name>
    <surname>Nsanzimana</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Saravanan</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Charpentier</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Mutational correlates of Virological failure in individuals receiving a WHO-recommended Tenofovir-containing first-line regimen: an international collaboration</article-title>
  <source>EBioMedicine</source>
  <year>2017</year>
  <volume>18</volume>
  <fpage>225</fpage>
  <lpage>235</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ebiom.2017.03.024</pub-id>
  <pub-id pub-id-type="pmid">28365230</pub-id>
 </element-citation>
</ref>
